Compounds > benzoyl-pro-phe-arg-p-nitroanilide

benzoyl-pro-phe-arg-p-nitroanilide and Thrombophlebitis

benzoyl-pro-phe-arg-p-nitroanilide has been researched along with Thrombophlebitis* in 1 studies

Other Studies

1 other study(ies) available for benzoyl-pro-phe-arg-p-nitroanilide and Thrombophlebitis

ArticleYear
Factor XII assay with the chromogenic substrate chromozym PK.
    Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 1981, Volume: 19, Issue:6

    A chromogenic assay for the determination of factor XII using the chromogenic substrate Chromozym PK was evaluated. The assay was linear in the range 10 U/l to more than 200 U/l. Using the assay, the normal range of factor XII (50 healthy volunteers at random) was 136 U/l +/- 27 U/l. Kallikrein-inhibiting concentrations of aprotinin did not influence factor XII. Comparison of the chromogenic with the clotting assay resulted in a correlation coefficient of r = 0.831 (p-value less than 0.001). In patients with deep vein thrombosis, factor XII level was found to be reduced to about 60% of normal activity.

    Topics: Adult; Aged; Aprotinin; Blood Preservation; Chromogenic Compounds; Drug Stability; Factor XII; Female; Humans; Male; Middle Aged; Oligopeptides; Photometry; Thrombin Time; Thrombophlebitis

1981